BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1815055)

  • 1. Area-based estimation of the initial volume of distribution and elimination rate constant following intravenous bolus injection.
    Khor SP; Johnson SL; Mayersohn M
    J Pharm Sci; 1991 Nov; 80(11):1042-50. PubMed ID: 1815055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of variation in drug elimination on five methods for assessing zero-order drug absorption rates.
    Cheng HY; Jusko WJ
    Pharm Res; 1990 Jan; 7(1):76-9. PubMed ID: 2300540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The area function method for assessing the drug absorption rate in linear systems with zero-order input.
    Cheng H; Jusko WJ
    Pharm Res; 1989 Feb; 6(2):133-9. PubMed ID: 2762213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Method for the Estimation of Absorption Rate Constant in Two-Compartment Model by Extravascular Administration.
    Zeng Y; Liu J; Liu W; Jiang S; Wang S; Cheng Z
    J Pharm Sci; 2020 May; 109(5):1802-1810. PubMed ID: 32032589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Loo-Riegelman absorption method.
    Wagner JG
    J Pharmacokinet Biopharm; 1975 Feb; 3(1):51-67. PubMed ID: 1127578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Jun; 96(6):1638-52. PubMed ID: 17117429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.
    Cheng HY; Jusko WJ
    Pharm Res; 1988 Mar; 5(3):156-64. PubMed ID: 3244627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug redistribution and mean transit time concepts for nonlinear pharmacokinetic systems.
    Cheng HY; Jusko WJ
    Biopharm Drug Dispos; 1991; 12(1):73-9. PubMed ID: 2039813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Michaelis-Menten metabolite formation kinetics: equations relating area under the curve and metabolite recovery to the administered dose.
    Chow AT; Jusko WJ
    J Pharm Sci; 1990 Oct; 79(10):902-6. PubMed ID: 2280360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the importance of exposure variability to the doses of volatile organic compounds.
    Rappaport SM; Kupper LL; Lin YS
    Toxicol Sci; 2005 Feb; 83(2):224-36. PubMed ID: 15548640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Jun; 93(6):1628-40. PubMed ID: 15124219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited sampling strategies to estimate the area under the concentration-time curve. Biases and a proposed more accurate method.
    Tsuruta H; Fukumoto M; Bax L; Kohno A; Morishita Y
    Methods Inf Med; 2012; 51(5):383-94. PubMed ID: 22614791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration.
    Haug KG; Weber B; Hochhaus G; Butterweck V
    Eur J Pharm Sci; 2012 Jan; 45(1-2):79-89. PubMed ID: 22085634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of glomerular filtration rate by sinistrin clearance using various approaches.
    Buclin T; Sechaud R; Bertschi AP; Decosterd LA; Belaz N; Appenzeller M; Burnier M; Biollaz J
    Ren Fail; 1998 Mar; 20(2):267-76. PubMed ID: 9574452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An initial slope method for model structure: independent estimation of the elimination rate constant of a metabolite.
    Piotrovskii VK
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):311-8. PubMed ID: 1875284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An area function method for estimating the apparent absorption rate constant.
    Cheng H; Staubus AE; Shum L
    Pharm Res; 1988 Jan; 5(1):57-60. PubMed ID: 3244611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.